KCT0007311招募中未知
Changes in anti-SARS-CoV-2 antibody levels in response to COVID-19 vaccine in patients with inflammatory bowel disease
Keimyung University Dongsan Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 20(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •1. Patients who will receive or have received a SARS-CoV-2 booster vaccine among IBD patients aged 20 to 80 years
- •2. Crohn's disease or ulcerative colitis patients who taking at least one of agents among 5-aminosalycylic acid (ASA), immunomodulatory agents, and biological agents (infliximab, vedolizumab, ustekinumab etc)
- •3. A person who has signed a written consent form after agreeing to the purpose and method of the clinical research
排除标准
- •1. Those who have passed the booster vaccination more than 12 months ago
- •2. Those who have been diagnosed with IBD and have used IBD medications for less 3 months
- •3. Those who have had surgery within 3 months at the time of registration
- •4. Those who do not agree to participate in the research
研究者
相似试验
已完成
不适用
Changes in antibody titer after SARS-CoV-2 vaccination of patients with in-center and home dialysisJPRN-UMIN000046281Reiseikai Medical Corporation Shinagawa Garden Clinic96
招募中
不适用
Periodic Change in Antibody titers against SARS-CoV-2 among COVID-19 positive patients: A Observational Cohort StudyCTRI/2021/01/030186Indian Council of Medical Research New Delhi
招募中
不适用
Seroprevalence of anti-SARS-CoV-2 antibody in response to COVID-19 vaccine in patients with i nflammatory bowel diseaseKCT0006901Keimyung University Dongsan Hospital150
进行中（未招募）
不适用
Survey on the SARS-CoV-2 additional vaccinatioSevere acute respiratory syndrome coronavirus 2SARS-CoV-2 infectionD000086402JPRN-jRCT1061210049akano Takashi1,500
招募中
不适用
SARS-CoV-2 immune responseCOVID-1910047438NL-OMON55057Diakonessenhuis Utrecht800